International Journal of Cardiovascular Sciences. 01/Oct/2019;32(5):435-7.
Rheumatic Heart Disease – How are We in 2019, Have We Evolved?
DOI: 10.5935/2359-4802.20190041
Rheumatic Heart Disease – How are We in 2019, Have We Evolved?
323
How to cite this article
Soares AM. Rheumatic Heart Disease – How are We in 2019, Have We Evolved?. Int. J. Cardiovasc. Sci. 2019;32(5):435-7.
Soares, Andressa Mussi. Rheumatic Heart Disease – How are We in 2019, Have We Evolved?. Int. J. Cardiovasc. Sci., v. 32, n. 5, p. 435-437, Oct. 2019.
Soares, A. M. (2019). Rheumatic Heart Disease – How are We in 2019, Have We Evolved?. Int. J. Cardiovasc. Sci., 32(5), 435-437.
Soares, Andressa Mussi. Rheumatic Heart Disease – How are We in 2019, Have We Evolved?. Int. J. Cardiovasc. Sci. [online]. 2019, vol. 32, n. 5, [cited 2025-09-23], pp.435-437. Available from: <https://ijcscardiol.org/article/rheumatic-heart-disease-how-are-we-in-2019-have-we-evolved/>. ISSN 2359-4802.
Central Illustration:
Chocolate Consumption Does Not Reduce the Risk of Cardiovascular Events and Increases the Risk of Gastrointestinal Bleeding One Year After the First Myocardial Infarction MACE: major adverse cardiovascular events; HR: hazard ratio; CI : confidence interval.